Table 3.
Clinical outcome measures (ANCOVAs, adjusted for baseline score)
| ‘Florence & TAU’ | TAU | Difference (95% CI) | |||||
|---|---|---|---|---|---|---|---|
| N | Mean | s.d. | N | Mean | s.d. | ||
| DIALOG PROM mean score 8 items | |||||||
| - at baseline | 30 | 4.6 | 0.8 | 24 | 4.3 | 1.4 | |
| - post-treatment | 30 | 4.8 | 1.1 | 24 | 4.6 | 1.2 | −0.27 (−0.51 to −0.02) * |
| DIALOG PREM mean score 3 items | |||||||
| - at baseline | 31 | 5.6 | 0.9 | 25 | 5.1 | 1.4 | |
| - post-treatment | 31 | 5.7 | 1.0 | 25 | 5.3 | 1.0 | −0.14 (−0.49 to 0.20) n.s. |
| General Self Efficacy Scale (GSE) | |||||||
| - at baseline | 30 | 2.8 | 0.7 | 23 | 2.7 | 0.8 | |
| - post-treatment | 30 | 2.7 | 0.7 | 23 | 2.8 | 0.6 | 0.16 (−0.17 to 0.20) n.s. |
| Mental Health Confidence Scale | |||||||
| - at baseline | 29 | 65.4 | 15.4 | 24 | 61.8 | 19.5 | |
| - post treatment | 29 | 62.4 | 17.2 | 24 | 66.5 | 15.5 | −0.85 (−4.97 to 3.23) n.s. |
| Medication Adherence Scale (MARS) | |||||||
| - at baseline | 31 | 7.7 | 2.1 | 25 | 7.6 | 2.7 | |
| - post-treatment | 31 | 7.6 | 2.3 | 25 | 7.7 | 2.1 | −0.14 (−0.79 to 0.50) n.s. |
DIALOG PROM: Patient Reported Outcome Measures, mean across 8 domains (mental health, physical health, job situation, accommodation, leisure activities, relationships, friendships, personal safety); DIALOG PREM: Patient Reported Experience Measures, mean across 3 domains (satisfaction with: medication, practical help, meetings); n.s not significant; TAU Treatment as usual; * The mean difference is significant at the .05 level.
*Each Scale is positively ranked where higher scores indicate higher satisfaction/efficacy/confidence/adherence